Evidence map›Paper›PMID 42682019›Full record

ReviewBiochemical Society transactions2026

Distinct functions of mammalian RAD51 paralogs in genome maintenance.

Harsh Kumar Dwivedi, Debanjali Bhattacharya, Shariva Kadupatil, Ganesh Nagaraju

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Harsh Kumar DwivediDepartment of Biochemistry, Indian Institute of Science, Bangalore 560012, India.ORCID 0000-0001-9862-111X
Debanjali BhattacharyaDepartment of Biochemistry, Indian Institute of Science, Bangalore 560012, India.
Shariva KadupatilDepartment of Biochemistry, Indian Institute of Science, Bangalore 560012, India.
Ganesh NagarajuDepartment of Biochemistry, Indian Institute of Science, Bangalore 560012, India.ORCID 0000-0002-3386-7095

Funding

Department of Biotechnology, Ministry of Science and Technology, India (DBT) BT/PR45508/MED/30/2414/2022
6 · The paper itself

Abstract

RAD51 paralogs (RAD51B, RAD51C, RAD51D, XRCC2, and XRCC3) are evolutionarily conserved essential proteins for cell survival and genome maintenance. RAD51 paralogs were originally identified to play a role in homologous recombination-mediated repair of DNA double-strand breaks (DSBs). However, investigations over the last decade have uncovered new roles of RAD51 paralogs beyond DSB repair in replication stress responses, including replication fork progression, fork stability, and its restart. Recent structural studies have not only uncovered the molecular architecture of previously known RAD51 paralog complexes but also identified novel paralog complex assemblies, providing mechanistic insights into their various genome-maintenance functions. Additionally, a role for RAD51 paralogs in resolving R-loops has been identified, and studies with cancer-associated variants suggest that RAD51 paralogs are potential determinants of cancer susceptibility and therapeutic responses. In the present review, we highlight the recently deciphered structures and novel functions of RAD51 paralog complexes and discuss the clinical and therapeutic implications.

Indexed as

DNA-Binding ProteinsRad51 RecombinaseAnimalsDNA Breaks, Double-StrandedDNA RepairDNA ReplicationGenomic InstabilityHumansNeoplasmsDNA-Binding ProteinsRAD51B protein, humanRAD51C protein, humanRAD51D protein, humanRad51 RecombinaseX-ray repair cross complementing protein 3XRCC2 protein, humanCancerDNA synthesis and repairgenome integrityRAD51RAD51 paralogs

Identifiers

PMID42682019
PMCPMC13538139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.